Kwan AYM, Gerstein HC, Basile J, Xavier D, et al. HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial. Diabetes Care 2022 Jan 19. pii: 140923. doi: 10.2337/dc21-1160.
PMID: 35043140